Table 1.
Study | Author and year | Country | Age (years) (IG vs. CG) | DM type | Follow-up (years) | HbA1c at baseline (IG vs. CG) | Achieved HbA1c (IG vs. CG) |
---|---|---|---|---|---|---|---|
DCCT | DCCT group, 1993 | USA | 27 | T1DM | 10 | Primary prevention: 8.8%; secondary prevention: 8.9% | 7.2% vs. 8.0% |
UKPDS | UKPDS group, 1998 | UK | 63 | T2DM | 15 | 9.3% vs. 9.4% | 7.1% vs. 7.9% |
VADT | Duckworth 2009, Azad 2014 | USA | 60 | T2DM | 6 | 9.3% vs. 9.4% | 6.9% vs. 8.4% |
ACCORD | ACCORD group, 2010 | USA | 61.6 | T2DM | 4 | 8.2% vs. 8.2% | 7.1% vs. 9.4% |
AdRem | Beulens, 2009 | 20 countries | 66 | T2DM | 4.1 | 7.4% vs. 7.4% | 6.49% vs. 7.24% |
DM = diabetes; T1DM = type 1 diabetes; T2DM = type 2 diabetes; IG = intensive glycemia control group; CG = conventional glycemic control group.